Search

Filters

Clear All
  • 49
  • 60
  • 6
  • 3
  • 498

Phase

  • 18
  • 15
  • 3
  • 15
  • 6
  • 15
  • 2
  • 439
  • 582
  • 229
  • 606
  • 10
  • 56
  • 27
  • 1
  • 615

Found 616 results

A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

A Randomized Phase II Study Comparing Single-Agent Olaparib, Single Agent Cediranib, and the Combination of Cediranib/Olaparib in Women With Recurrent, Persistent or Metastatic Endometrial Cancer

18 years - 100 years
Female
This phase II trial studies how well olaparib and cediranib maleate work in treating patients with endometrial cancer that has come back, does not respond to treatment, or has spread to other places in the body.

Feasibility, Acceptability and Preliminary Effects of the Spiritual Care Assessment and Intervention (SCAI) Framework for Adults With Advanced Cancer and Their Caregivers (FCGs): A Clinical Pilot Trial

18 years - 100 years
Accepts healthy volunteer
All genders
The purpose of this study is to test a spiritual care intervention for adults with advanced cancer and their caregivers.

PROSPECTIVE MULTI-CENTER EVALUATION OF THE DURATION OF THERAPY FOR THROMBOSIS IN CHILDREN (the "Kids-DOTT" Trial)

All genders
This study plans to learn more about the best type of treatment for children with blood clots in the veins.

Phase 3 Accelerated BEP Trial: A randomised phase 3 trial of accelerated versus standard BEP chemotherapy for patients with intermediate and poor-risk metastatic germ cell tumours

11 years - 45 years
All genders
The purpose of this study is to determine if accelerated BEP will be more effective but not significantly more toxic than standard BEP.

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate Pembrolizumab Versus Placebo as Adjuvant Therapy Following Surgery and Radiation in Participants with High-risk Locally Advanced Cutaneous Squamous Cell Carcinoma(LA cSCC) (KEYNOTE-630).

18 years - 100 years
All genders
The purpose of this study is to compare the recurrence-free survival (RFS), as assessed by the investigator and confirmed by biopsy, in individuals who receive pembrolizumab with individuals who receive placebo as adjuvant therapy.

ACCL1633, The Effectiveness of Lactobacillus plantarum in Preventing Acute Graft-versus-Host Disease (GvHD) in Children undergoing Alternative Hematopoietic Progenitor Cell Transplantation (HCT)

2 years - 25 years
All genders
The purpose of this study is to find out if the probiotic Lactobacillus plantarum (LBP) will prevent the development of GI aGvHD in children, adolescents, and young adults undergoing alternative alloHCT.

Long-term Recovery in OUD

18 years - 100 years
All genders
The goals of this project are: 1) Establish normative data on long-term recovery course of OUD across patients, community supports, and providers and 2) Quantify the impact of MAT on long-term recovery from OUD.

Tocotrienol Against the Progression of End Stage Liver Disease

18 years - 100 years
All genders
The purpose of this study is to see if oral tocotrienol (TCT) will significantly reduce the rise in Model for End Stage Liver Disease (MELD) score over time in patients with Nonalcoholic Steatohepatits (NASH).

Effectiveness of two different forms of marine oil, derived from the New Zealand green lipped mussel (Perna canaliculus) and krill oil (Euphausia superba), on indirect markers of muscle damage and soreness during recovery from muscle damaging exercise in untrained men: a randomized controlled non-inferiority trial

18 years - 30 years
Male
The purpose of this study is to evaluate the effects of PCSO-524®, and a blend of PCSO-524® (75%) and krill oil (25%) (ESPO-572®), on indirect markers of muscle damage, inflammation and soreness during recovery from muscle damaging exercise.

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Ataluren in Patients with Nonsense Mutation Duchenne Muscular Dystrophy and Open-Label Extension

7 years - 100 years
Male
This study is being done to see if Ataluren will slow the progression of DMD in boys with DMD who have specific mutations.
371 - 380 of 616